In addition, Lou et al. demonstrated that MnSOD-overexpressing oncolytic vaccinia virus (OVV-MnSOD) enhanced lymphocyte infiltration and tumour sensitivity to anti-PD-L1 treatment in lymphomatous mice, suggesting a promising therapeutic potential of MnSOD in cancer immunotherapy [63]. The gene discussed is SOD2; the disease is neoplasm.